Published on
April 28, 2026
- 13:00 GMT
Scipher Medicine’s PrismRA Further Validated In Trial Demonstrating Improved Outcomes For Hispanic RA Patients
BURLINGTON, MA, UNITED STATES, April 28, 2026 /EINPresswire.com/ -- Scipher Medicine, a leader in precision medicine for autoimmune diseases, today highlighted a publication of peer-reviewed, real-world evidence showing that its molecular treatment …
Distribution channels:
Banking, Finance & Investment Industry, Business & Economy
...
